Pfizer Inc. Spends $189M on French Inhaled Meds Unit; 440 New Jobs in 5 Years

LONDON, Feb 12 (Reuters) - Pfizer Inc, the world’s biggest drugmaker, said on Tuesday it was investing 130 million euros ($189 million) to set up an inhaled medicines unit at its Amboise production plant in France.

MORE ON THIS TOPIC